Роль колоноскопии в диагностике дисплазии и рака толстой кишки при язвенном колите


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Доступ платный или только для подписчиков

Аннотация

У больных с воспалительными заболеваниями кишечника высок риск развития дисплазии и колоректального рака, что обусловливает необходимость эндоскопических и гистологических исследований. От их результатов напрямую зависит тактика ведения таких пациентов, во многих случаях требующая мультидисциплинарного подхода.

Полный текст

Доступ закрыт

Об авторах

Р. Куваев

Клиническая онкологическая больница

Email: kuvaev_roman@mail.ru
кандидат медицинских наук Ярославль

С. Кашин

Клиническая онкологическая больница

кандидат медицинских наук Ярославль

Д. Завьялов

Клиническая онкологическая больница

Ярославль

Список литературы

  1. Ивашкин В.Т., Шелыгин Ю.А., Абдулганиева Д.И. и др. Рекомендации Российской гастроэнтерологической ассоциации и Ассоциации колопроктологов России по диагностике и лечению взрослых больных язвенным колитом // РЖГГК. - 2015; 25 (1): 48-65.
  2. Marchal J., Hilsden R. Environment and epidemiology of inflammatory bowel disease in Inflammatory bowel disease. Ed. J. Satsangi, L. Sutherland / Churchill-Livingstone, 2003; 17-28.
  3. Ивашкин В.Т., Комаров Ф.И., Рапопорт С.И. Краткое руководство по гастроэнтерологии / М.: М-Вести, 2001; 464 с.
  4. Ekbom A., Lцfberg, R. Cancer in inflammatory bowel disease - clinical considerations. In: R.B. Sartor, W.J. Sandborn (eds.): Kirsner’s Inflammatory Bowel Diseases; 6th edition / Philadelphia: W.B. Saunders Company, 2004; 641-6.
  5. Brostrum O., Lufberg R., Nordenvall B. et al. The risk of colorectal cancer in ulcerative colitis. An epidemiologic study // Scand. J. Gastroenterol. - 1987; 22: 1193-9.
  6. Ransohoff D. Colon cancer in ulcerative colitis (Editorial) // Gastroenterology. -1988; 94: 1089-91.
  7. Eaden J., Abrams K., Mayberry J. The risk of colorectal cancer in ulcerative colitis: a meta-analysis // Gut. - 2001; 48: 526-35.
  8. Jess T., Loftus Jr. E., Velayos F. et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota // Gastroenterology. - 2006; 130: 1039-46.
  9. Ekbom A., Helmick C., Zack M. et al. Ulcerative colitis and colorectal cancer. A population-based study // N. Engl. J. Med. - 1990; 323: 1228-33.
  10. Heuschen U., Hinz U., Allemeyer E. et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis // Gastroenterology. -2001; 120: 841-7.
  11. Rutter M., Saunders, B., Wilkinson, K. et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis // Gastroenterology. - 2004; 126: 451-9.
  12. Pinczowski D., Ekbom A., Baron J. et al. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study // Gastroenterology. - 1994; 107: 117-20.
  13. Rutter M., Saunders B., Wilkinson K. et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis // Gastroenterology. - 2004; 126: 451-9.
  14. Askling J., Dickman P., Karlen P. et al. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study // Lancet. - 2001; 357: 262-6.
  15. Lindberg B., Broom U., Persson B. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study // Dis. Colon Rectum. - 2001; 44: 77-85.
  16. Annese V., Daperno M., Rutter M. et al. European Crohn's and Colitis Organisation European evidence based consensus for endoscopy in inflammatory bowel disease // J. Crohns Colitis. - 2013; 7 (12): 982-1018.
  17. Rutter M., Saunders B., Wilkinson K. et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis // Gastroenterology. - 2004; 126: 451-9.
  18. Lebwohl B., Kastrinos F., Glick M. et al. The impact of suboptimal bowel preparation on adenoma miss rates and the factors associated with early repeat colonoscopy // Gastrointest. Endosc. - 2011; 73 (6): 1207-14.
  19. Nett A., Velayos F., McQuaid K. Quality bowel preparation for surveillance colonoscopy in patients with infl ammatory bowel disease is a must // Gastrointest. Endosc. Clin. N. Am. - 2014; 24 (3): 379-92.
  20. Hassan C., Bretthauer M., Kaminski M., et al. European Society of Gastrointestinal Endoscopy. Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline // Endoscopy. - 2013; 45 (2): 142-50.
  21. DiPalma J., Marshall J. Comparison of a new sulfate-free polyethylene glycol electrolyte lavage solution versus a standard solution for colonoscopy cleansing // Gastrointest. Endosc. - 1990; 36 (3): 285-9.
  22. Щербаков П.Л., Парфенов А.И., Албулова Е.В. Новые схемы подготовки кишечника к колоноскопии // Лечащий врач. - 2014; 11: 75-80.
  23. Johnson D., Barkun A., Cohen L. et al. Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the US Multi-Society Task Force on Colorectal Cancer // Gastroenterology. - 2014; 147 (4): 903-24.
  24. Lasisi F., Rex D. Improving protection against proximal colon cancer by colonoscopy // Expert Rev. Gastroenterol. Hepatol. - 2011; 5 (6): 745-54.
  25. Cohen L. Split dosing of bowel preparations for colonoscopy: an analysis of its effi cacy, safety, and tolerability // Gastrointest. Endosc. - 2010; 72 (2): 406-12.
  26. Rex D., Cutler C., Lemmel G. et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies // Gastroenterology. - 1997; 112: 243-8.
  27. Rex D., Bond J., Winawer S. et al. Quality in the Technical Performance of Colonoscopy and the Continuous Quality Improvement Process for Colonoscopy: Recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer // Am. J. Gastroenterol. - 2002; 97 (6): 1296-308.
  28. Hurlstone D., McAlindon M., Sanders D. et al. Further validation of high-magnification chromoscopic-colonoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis // Gastroenterology. - 2004; 126: 376-8.
  29. Кашин С.В. Современные аспекты выполнения колоноскопии с целью скрининга полипов и колоректального рака // Доказательная гастроэнтерол. - 2012; 2: 89-99.
  30. van den Broek F., Fockens P., van Eeden S. et al. Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of highresolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions // Gut. - 2008; 57: 1083-9.
  31. Nakamura K. Further Development of Endoscopic Imaging: “Era of Light” Activities with Optics and Image Processing Technology In book: New Challenges in Gastrointestinal Endoscopy / Springer,2008; p 40-55.
  32. van den Broek F., Fockens P., van Eeden S. et al. Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomized comparison of highresolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrowband imaging for classification of lesions // Gut. - 2008; 57: 1083-19.
  33. Rutter M., Saunders B., Wilkinson K. et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis // Gastroenterology. - 2006; 130: 1030-8.
  34. Watanabe K., Sogawa M., Yamagami H. et al. Endoscopic differential diagnosis between ulcerative colitis-associated neoplasia and sporadic neoplasia in surveillance colonoscopy using narrow band imaging // Dig. Endosc. - 2011; 23: 1143-9.
  35. Rutter M. A practical guide and review of colonoscopic surveillance and chromoendoscopy in patients with colitis // Frontline Gastroenterology. - 2010; 1: 126-30. doi: 10.1136/fg.2010.001438
  36. Kaminski M., Hassan C., Bisschops R. et al. Advanced imaging for detection and differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE) Guideline // Endoscopy. - 2014; 46 (5): 435-57.
  37. Odze R., Farraye F., Hecht J. et al. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis // Clin. Gastroenterol. Hepatol. - 2004; 2: 534-41.
  38. Wanders L., Dekker E., Pullens B. et al. Cancer risk following resection of polypoid dysplasia in patients with long-standing ulcerative colitis: a meta-analysis // Clin. Gastroenterol. Hepatol. - 2013.
  39. Bernstein C., Shanahan F., Weinstein W. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? // Lancet. - 1994; 343: 71-4.
  40. Befrits R., Ljung T., Jaramillo E. et al. Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a followup study // Dis. Colon Rectum. - 2002; 45: 615-20.
  41. Lim C., Dixon M., Vail A. et al. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia // Gut. - 2003; 52: 1127-32.
  42. Ullman T., Croog V., Harpaz N. et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis // Gastroenterology. - 2003; 125: 1311-9.
  43. Connell W., Lennard-Jones J., Williams C. et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis // Gastroenterology. - 1994; 107: 934-44.
  44. Rutter M., Saunders B., Wilkinson K. et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk // Gut. - 2004; 53: 1813-6.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ИД "Русский врач", 2016

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах